NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Sharps Technology, an innovative medical device company introducing a new patented best in class single use safety syringe, today announced Robert Hayes will be joining the Sharps leadership team.
About Robert Hayes
Robert joined Gerresheimer Tubular Glass Americas in 2010, initially as Business Development Manager, then was promoted to Global Key-Account Manager, and was later promoted to Dir. of Commercial Quality. Currently, Robert is the Sr. Director of Innovation & Product Management overseeing the development and commercialization of specialized Pharmaceutical Packaging products for use in North America and Europe, including Elite Glass Technologies, Sterile Ready-To-Fill Systems, and Specialized Pharma Packaging Solutions for combination medical products and devices.
Robert has a BA from the University of Toledo and has ASQ Certifications in Quality Engineering and Management. His previous work experience includes Plant Manager for Amcor's pharmaceutical plastic packaging division and Director of Quality & Technical Services for their Tubular Glass division where he initiated and led Amcor's Custom Product Solution program. Robert also has extensive quality management and operations experience in the pharma/medical device industry working directly for companies such as: Boston Scientific, Hill Rom, Fresenius Medical, Cardinal Health, and Covidien.
Alan Blackman, Chairman and Founder, said, "Sharps has been seeking an engineering and technically oriented executive to lead the company as we go into full manufacturing and commercialization of the Sharps Provensa smart safety syringes. Given Hayes background, he is the best fit for the role."
About Sharps Technology
Sharps Technology offers a solution to a global healthcare crisis. The Sharps Provensa smart safety syringes are the first of their kind designed to eliminate two million potentially infectious, accidental needlestick injuries, as well as billions of dollars in medicine wasted with today's inefficient syringes. Sharps Provensa syringes address the important needs of the global healthcare market:
- Provides automatic protection from accidental needlestick injection for clinicians and all who come in contact with contaminated needles.
- Prevents improper reuse of both needle and syringe by automatically locking the plunger and shielded needle following injection.
- Ultra Low-Waste™ dramatically reduces the number of costly medications discarded with inefficient injections.
The needle tips go through the skin sharp, delivering the medicine or vaccine, and come out of the body shielded, protecting the healthcare worker and the public. For the first time ever, needlesticks can be completely avoided, easing the financial burden on the healthcare system and giving clinical staff and the general public total protection and true peace of mind.
Investor Relations Contact:
RedChip Companies Inc.
SOURCE: Sharps Technology